Annalisa Jenkins's Net Worth
$369 Thousand
Who is Annalisa Jenkins?
Annalisa Jenkins does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include COMPASS Pathways plc, Dimension Therapeutics, Inc., ARDELYX, INC., AVROBIO, Inc., AgeX Therapeutics, Inc., ONCOSEC MEDICAL Inc, Mereo BioPharma Group plc, and Skye Bioscience, Inc..
SEC CIK
Annalisa Jenkins's CIK is 0001639481
Past Insider Trading and Trends
2017 was Annalisa Jenkins's most active year for acquiring shares with 4 total transactions. Annalisa Jenkins's most active month to acquire stocks was the month of May. 2017 was Annalisa Jenkins's most active year for disposing of shares, totalling 6 transactions. Annalisa Jenkins's most active month to dispose stocks was the month of October. 2017 saw Annalisa Jenkins paying a total of $0.00 for 457,000 shares, this is the most they've acquired in one year. In 2022 Annalisa Jenkins cashed out on 3,384 shares for a total of $42,232.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COMPASS Pathways plc (CMPS) Snapshot price: $6.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| -1.06% | -211.00 |
$8.48 | -$1,789.28 | 19.64K |
May 1
| |||
Form 4
| -0.87% | -175.00 |
$11.34 | -$1,984.50 | 19.85K |
Feb 1
| |||
Form 4
| -0.71% | -143.00 |
$5.78 | -$826.54 | 20.03K |
Nov 1
| |||
Form 4
| -0.79% | -161.00 |
$8.95 | -$1,440.95 | 20.17K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| -0.12% | -25.00 |
$7.97 | -$199.25 | 20.33K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -14.25% | -3.38K |
$12.48 | -$42,232.32 | 20.36K |
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dimension Therapeutics, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARDELYX, INC. (ARDX) Snapshot price: $5.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +149.80% | 20.07K |
—
|
—
| 33.47K |
Jun 13
| |||
Form 4
|
∞
| 13.4K |
—
|
—
| 13.4K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVROBIO, Inc. (AVRO) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AgeX Therapeutics, Inc. (AGE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||